Comorbidities in psoriasis and their therapeutic implications

Authors

  • Ijaz Hussain Dermatology Department, Postgraduate Medical Institute /Lahore General Hospital, Lahore
  • Tahir Saeed Haroon Dermatology Department, King Edward Medical College/Mayo Hospital, Lahore

DOI:

https://doi.org/10.66344/jpad.v19i2.513

References

1. Myers WA, Gottlieb AB, Mease P. Psoriasis and psoriatic arthritis: clinical features and disease mechanisms. Clin Dermatol 2006; 24: 438-47.

2. Boehncke W-H, Sterry Wolfram. Psoriasis – a systemic inflammatory disorder: clinic, pathogenesis and therapeutic perspectives. JDOG 2009; 9:

3. Gottlieb AB, Dann F, Menter A. Psoriasis and the metabolic syndrome. J Drugs Dermatol 2008; 7: 563-72.

4. Kourosh AS, Miner A, Menter A. Psoriasis as the marker of underlying systemic disease. Skin Therapy Lett 2008; 13: 1-5.

5. Kaye IA, Jick SS. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol 2008; 159: 895-902.

6. Wu Y, Mills D, Bala M. Psoriasis: cardiovascular risk factors and other disease comorbidities. J Drugs Dermatol 2008; 7: 373-7.

7. Dreiher J, Weitzman D, Shapiro J et al. Psoriasis and chronic obstructive pulmonary disease: a case-control study. Br J Dermatol 2008; 159: 956-60.

8. Setty AR, Curhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women- Nurses' Health Study II. Arch Intern Med 2007; 167: 1670-5.

9. Gerdes S, Zahl VA, Knopf H et al. Comedication related to comorbidities: a study in 1203 hospitalized patients with severe psoriasis. Br J Dermatol 2008; 159: 1116-23.

10. Sommer DM, Jenisch S, Suchan M et al. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006; 298: 321-8.

11. Neimann AL, Shin DB, Wang X et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006; 55: 829-35.

12. Gisondi P, Tessari G, Conti A et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007; 157: 68-73.

13. Chen YJ, Wu CY, Shen JL et al. Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome. Arch Dermatol 2008; 144: 1571-5.

14. Cohen AD, Sherf M, Vidavsky L et al. Association between psoriasis and the metabolic syndrome. Dermatology 2008; 216: 152-5.

15. Johnson LW, Weinstock RS. The metabolic syndrome : concepts and controversy. Mayo Clin Proc 2006; 81: 1615-20.

Downloads

Published

24.12.2016

Issue

Section

Editorial

How to Cite

1.
Comorbidities in psoriasis and their therapeutic implications. J Pak Assoc Dermatol [Internet]. 2016 Dec. 24 [cited 2026 Aug. 18];19(2):63-5. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/513